Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Cell Reports
|
March 19, 2013
Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity
Jan P Böttcher, Oliver Schanz, Dirk Wohlleber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 8, 2016
Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4
Verena Schuette, Maria Embgenbroich, Thomas Ulas, et al.
Journal of Hepatology
|
January 21, 2023
Gut microbiota promote liver regeneration through hepatic membrane phospholipid biosynthesis
Yuhan Yin, Anna Sichler, Josef Ecker, et al.
Cancer Cell
|
July 14, 2023
A distinct stimulatory cDC1 subpopulation amplifies CD8<sup>+</sup> T cell responses in tumors for protective anti-cancer immunity
Philippa Meiser, Moritz A Knolle, Anna Hirschberger, et al.
Cancer Cell
|
October 15, 2014
Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes
Monika Julia Wolf, Arlind Adili, Kira Piotrowitz, et al.
Gut
|
August 4, 2023
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8<sup>+</sup> T cells
Frances Winkler, Anna V Hipp, Carlos Ramirez, et al.
Frontiers in Immunology
|
May 7, 2025
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response
Teng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Frontiers in Immunology
|
February 11, 2026
Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon response
Teng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
April 13, 2023
Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes
Knud Esser, Xiaoming Cheng, Jochen M Wettengel, et al.
Immunity
|
June 14, 2023
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
Felix Bayerl, Philippa Meiser, Sainitin Donakonda, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Cell Reports
|
March 19, 2013
Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity
Jan P Böttcher, Oliver Schanz, Dirk Wohlleber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 8, 2016
Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4
Verena Schuette, Maria Embgenbroich, Thomas Ulas, et al.
Journal of Hepatology
|
January 21, 2023
Gut microbiota promote liver regeneration through hepatic membrane phospholipid biosynthesis
Yuhan Yin, Anna Sichler, Josef Ecker, et al.
Cancer Cell
|
July 14, 2023
A distinct stimulatory cDC1 subpopulation amplifies CD8<sup>+</sup> T cell responses in tumors for protective anti-cancer immunity
Philippa Meiser, Moritz A Knolle, Anna Hirschberger, et al.
Cancer Cell
|
October 15, 2014
Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes
Monika Julia Wolf, Arlind Adili, Kira Piotrowitz, et al.
Gut
|
August 4, 2023
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8<sup>+</sup> T cells
Frances Winkler, Anna V Hipp, Carlos Ramirez, et al.
Frontiers in Immunology
|
May 7, 2025
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response
Teng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Frontiers in Immunology
|
February 11, 2026
Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon response
Teng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
April 13, 2023
Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes
Knud Esser, Xiaoming Cheng, Jochen M Wettengel, et al.
Immunity
|
June 14, 2023
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
Felix Bayerl, Philippa Meiser, Sainitin Donakonda, et al.
Page
of 5